Remove 2025 Remove Stroke Remove Thrombolysis
article thumbnail

Abstract WMP118: Thrombin generation is associated with outcome in patients with stroke treated with thrombolysis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWMP118-AWMP118, February 1, 2025. Background and Purpose:Thrombolysis can improve outcome in patients with acute ischemic stroke. Properties of the formed thrombus may influence thrombolysis efficiency and impede recanalization success.

article thumbnail

Abstract TMP33: Recanalization of intracranial vessel occlusion in Acute Ischemic Stroke and Thrombolysis “Dwell Time”

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATMP33-ATMP33, February 1, 2025. Introduction:Acute ischemic stroke (AIS) with large vessel occlusion (LVO) benefits from mechanical thrombectomy (MT), but the majority of Americans require interhospital transfer for MT. The mean time from LKN to thrombolysis was 2.2 hours vs 2.7

article thumbnail

Abstract TP8: Prolonged Low-Dose Intravenous Thrombolysis in early recurrent Stroke: ESR-PROLONG Study

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP8-ATP8, February 1, 2025. Introduction:Treatment of acute stroke has its clear rules and established standards. The neurological deficit corresponded to 5 points in the median NIHSS after a previous stroke, 11 points at the time of recurrence, and 7 points after rescue therapy.

article thumbnail

Abstract TP25: Benefits and Risks of Antiplatelet Versus Thrombolysis for Mild Acute Ischemic Stroke: Update of a Living Systematic Review and Meta-analysis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP25-ATP25, February 1, 2025. This study was registered in the PROSPERO.Results:Since July 2023, two new studies were added, for a total of three RCTs and five observational studies with 5526 patients(3333 treated with antiplatelet and 2193 treated with thrombolysis).

article thumbnail

Abstract WP11: Efficacy and Safety Outcomes of thrombolysis for stroke in Low- and Middle-Income countries: Systematic Review and Metanalysis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP11-AWP11, February 1, 2025. Introduction:Stroke is a leading cause of disability and mortality worldwide, with thrombolysis as a critical treatment. Studies aiming to assess the outcomes of thrombolysis after ischemic stroke in LMIC were selected.

article thumbnail

Abstract WP13: Determining Eligible Thrombolysis Candidates for Isolated Dizziness

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP13-AWP13, February 1, 2025. Introduction:Strokes affecting the posterior circulation (PCS) account for 20% of all ischemic strokes. The number of stroke mimics presenting with isolated dizziness who received thrombolysis was 11 in 2021, 16 in 2022, 9 in 2023, and 11 in 2024.

article thumbnail

Abstract 4: Thrombolysis with Tenecteplase in Minor Disabling versus Non-disabling Stroke: Secondary Analysis of the TEMPO-2 Trial

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page A4-A4, February 1, 2025. Introduction:The tenecteplase versus standard of care for minor ischemic stroke with proven occlusion (TEMPO-2) trial showed that patients presenting with minor deficits up to 12 h do not benefit from intravenous thrombolysis. vs control 2.1%, P=0.005.